feed,title,long_url,short_url
Benzinga,Here's Why Editas Stock Dropped After Data From CRISPR-Based Retinal Disorder Candidate,https://benzinga.com/general/biotech/21/09/23156069/heres-why-editas-stock-dropped-after-data-from-crispr-based-retinal-disorder-candidate,https://j.mp/3zRN8kC
Benzinga,Raymond James Cuts XPO Logistics Price Target By 35% - Read Why,https://benzinga.com/analyst-ratings/analyst-color/21/09/23158181/raymond-james-cuts-xpo-logistics-price-target-by-35-read-why,https://j.mp/3kU5z3U
